S
4119
vs
T
Taiwan Weighted Index
Over the past 12 months, SCI Pharmtech Inc has underperformed Taiwan Weighted Index, delivering a return of -35% compared to the Taiwan Weighted Index's +51% growth.
Stocks Performance
4119 vs Taiwan Weighted Index
Performance Gap
4119 vs Taiwan Weighted Index
Performance By Year
4119 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
SCI Pharmtech Inc
Glance View
SCI Pharmtech Corp. is engaged in the biotechnology and medical care industry. The company is headquartered in Taoyuan, Taoyuan. The company went IPO on 2002-08-12. The firm's main products include APIs, API intermediates and special and precision chemicals. The firm distributes its products in domestic market and to overseas markets, including Europe, the Americas, the rest areas of Asia and others